Skip to main content

Ocrevus Prices, Coupons and Patient Assistance Programs

Ocrevus (ocrelizumab) is a member of the CD20 monoclonal antibodies drug class and is commonly used for Multiple Sclerosis.

Ocrevus prices

The cost for Ocrevus intravenous solution (300 mg/10 mL) is around $18,750 for a supply of 10 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Ocrevus price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Intravenous Solution

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Ocrevus Coupons and Rebates

Ocrevus offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Ocrevus Co-Pay Program: Eligible commercially insured patients may pay as little as $5 copay per drug/infusion treatment per calendar year; maximum savings for drug costs is $20,000 per calendar year; maximum savings for infusion costs is $1500 in the first calendar year then $1000 each calendar year; for additional information contact the program at 844-672-6729.

Applies to:
Ocrevus
Number of uses:
Per prescription per calendar year

Form more information phone: 844-672-6729 or Visit website

Ocrevus Co-Pay Program Rebate: Eligible commercially insured patients who paid their provider directly for treatment may submit a rebate request; in order to be eligible for this offer patient must have paid their provider in full for treatment; for additional information contact the program at 844-672-6729.

Applies to:
Ocrevus
Number of uses:
One rebate per prescription fill

Form more information phone: 844-672-6729 or Visit website

Patient Assistance Programs for Ocrevus

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Ocrevus (ocrelizumab) Injection; IV

More information please phone: 866-316-7263 Visit Website

Provider: Genentech Access Solutions (Ocrevus)

Elligibility requirements:
  1. Determined case by case
  2. Based on FPL
  3. Medically appropriate condition/diagnosis
  4. Must be treated by US licensed healthcare provider
  5. Eligibility determined on a case-by-case basis. Contact program for details.
Applicable drugs:
  • Ocrevus (ocrelizumab) Injection; IV

More information please phone: 800-888-2882 Visit Website

Provider: Genentech Patient Foundation

Elligibility requirements:
  1. Uninsured or Underinsured with no prescription coverage for needed medication
  2. Based on FPL
  3. Medically appropriate condition/diagnosis
  4. Must be treated by US licensed healthcare provider
  5. The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Ocrevus (ocrelizumab) Injection; IV

More information please phone: 888-941-3331 Visit Website